Sanofi appoints Pfizer’s Rita Balice-Gordon to lead neurobiology research

Sanofi has appointed Rita Balice-Gordon as head of its neurobiology research therapeutic area. She joins the French pharma firm from Pfizer, where she served as head of circuits, neurotransmitters and signaling in the its neuroscience and pain research unit. During her time there she led a global team and was responsible for the company’s worldwide research and development postdoctoral programme. Prior to her time at Pfizer Balice-Gordon was professor of neuroscience and chair of the neuroscience graduate group in the Perelman School of Medicine at the University of Pennsylvania, where she currently holds an adjunct appointment. In her new role at Sanofi Balice-Gordon will based at the firm’s Framingham, Massachusetts R&D site and lead research efforts associated with Sanofi’s early portfolio in neurobiology, including neurodegeneration, neuroinflammation and central nervous system inherited…


Link to Full Article: Sanofi appoints Pfizer’s Rita Balice-Gordon to lead neurobiology research